Charité - Universitätsmedizin Berlin

Berlin, Germany 13353

1 studies enrolling now · 1 studies all time

What they study most

Melanoma, Metastatic Melanoma, Unresectable Melanoma

Studies at this site

• Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. — Recruiting now